April 11-13, 2016,Winning ventures won the 2015 annual China best funded venture investment institutions TOP50 and China cutting-edge venture investment institutions TOP10 at the annual meeting of China Venture.

Mr. Yu Wenbin (right four), a partner of winning ventures, took the podium to accept the award.

Act with reatraint on the base of a large accumulation. Just a day after the Winning ventures  capture another project.

April 14, 2016, ErKang Pharmaceutical (300267.SZ) announced that they will invested 2.4 billion yuan and Winning ventures to sponsor the establishment of industry mergers and acquisitions fund focused on the medical and health industry. The fund size is 1 billion, which will promote the implementation of the strategic objectives of the whole ErKang pharmaceutical and expand the company's upstream and downstream industry chain, enhance the overall competitiveness of the company, the company to cultivate a new profit growth point, promote the company's benign operation and sustainable development.

Winning Venture Capital deeply focus on health and medical industry investment,covering start-up stage, growth stage, Pre-IPO stage, mergers and acquisitions. Our mission is to help entrepreneurs to invest in innovative technologies for human health promotion. We value greatly in outstanding entrepreneurial team, leading science and technology. Due to the long-term focus on health care industry, we have accumulated unique resources to support the development of enterprise in the local and multinational markets.